ebook Munafa Stock Market Course + Intraday & FNO calls  

       

AUROPHARMA announcements Aurobindo Pharma Limited announcements and dividends declared NSE

Aurobindo Pharma Limited Complete list of announcements declared & dividend announcements by Aurobindo Pharma Limited AUROPHARMA

Aurobindo Pharma Limited AUROPHARMA listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Aurobindo Pharma Limited AUROPHARMA

Company Announcement

Announcement as on 10 February 2026

Company Announcement
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated February 09, 2026, titled "Press Release on Unaudited Financial Results of the Company for the third quarter and nine months period ended December 31, 2025.".
Announcement as on 10 February 2026

Aurobindo Pharma Q3FY26 results: Net profit rises 8% to ?910 crore
Aurobindo Pharma on Monday said its consolidated net profit increased 8 per cent year-on-year to Rs 910 crore for the December quarter, led by robust sales in Europe and the US. The Hyderabad-based drug major reported a net profit of Rs 846 crore for the O
Announcement as on 09 February 2026

Company Announcement
Aurobindo Pharma Limited has informed the Exchange about completion of US FDA Inspection at Unit III of Eugia Pharma Specialities Ltd., a wholly owned subsidiary company
Announcement as on 09 February 2026

Q3 results: Pfizer, Zydus Lifesciences, Aurobindo Pharma, 181 more on Feb 9
Q3FY26 company results: Firms including GlaxoSmithKline Pharmaceuticals, The Ramco Cements, Linde India, Gulf Oil Lubricants, and Bata India are also to release their October-December earnings today
Announcement as on 09 February 2026

Announcements by Aurobindo Pharma Limited first page | Next page | Prev page |

AUROPHARMA Aurobindo Pharma Limited current price & indicator signals

Moving Averages for Aurobindo Pharma Limited

  • 5Day Average: 1294.74
  • 12Day Average: 1289.08
  • 20Day Average: 1265.33
  • 50Day Average: 1206.32
  • 100Day Average: 1202.56
  • 150Day Average: 1163.14
  • 200Day Average: 1152.6

AUROPHARMA Indicators & signals

Indicator MACD (12,26,9)

1281.38, 1254.16, 25.79
Indicator MACD is in positive zone

Indicator ADX (14)

12.68, 23.28, 18.04
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of AUROPHARMA Aurobindo Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
27 Fri Mar 2026 1314.20 1296.00 to 1327.00 0.49% 1.27 times
25 Wed Mar 2026 1307.80 1282.10 to 1330.00 2.04% 1.25 times
24 Tue Mar 2026 1281.60 1255.40 to 1310.00 0.23% 1.17 times
23 Mon Mar 2026 1278.70 1268.30 to 1299.00 -0.98% 1.16 times
20 Fri Mar 2026 1291.40 1258.30 to 1297.80 3.52% 0.92 times
19 Thu Mar 2026 1247.50 1240.00 to 1269.00 -1.69% 0.54 times
18 Wed Mar 2026 1269.00 1265.30 to 1290.50 -1.32% 1.12 times
17 Tue Mar 2026 1286.00 1275.10 to 1295.00 0.5% 0.42 times
16 Mon Mar 2026 1279.60 1265.80 to 1314.00 -1.3% 0.95 times
13 Fri Mar 2026 1296.50 1288.10 to 1317.80 -1.17% 1.08 times
12 Thu Mar 2026 1311.90 1289.40 to 1319.80 0.54% 1.39 times
11 Wed Mar 2026 1304.80 1290.00 to 1318.50 1.47% 1.68 times

Videos related to: AUROPHARMA announcements Aurobindo Pharma Limited announcements and dividends declared NSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

AUROPHARMA announcements Aurobindo Pharma Limited announcements and dividends declared NSE

 

Back to top